PROF

Profound Medical Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth 2/10
  • Value 0/10
Profound Medical sales and earnings growth
PROF Growth
Fair
  • Revenue Y/Y 58.61%
  • EPS Y/Y -3.33%
  • FCF Y/Y -41.53%
Profound Medical gross and profit margin trends
PROF Profitability
Neutral
  • Gross margin 71.10%
  • EPS margin -206.80%
  • ROIC 5Y -210.82%
Profound Medical net debt vs free cash flow
PROF Risk
Great
  • Debt / Equity 0.1
  • Debt / FCF 0.0
  • Interest coverage -39.6

Profound Medical stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Medical Devices stocks